dc.contributor.author | Derfuss, Tobias | |
dc.contributor.author | Siva, Axel | |
dc.contributor.author | Montalban, Xavier | |
dc.contributor.author | Gold, Ralf | |
dc.contributor.author | Thompson, Alan J. | |
dc.contributor.author | Otero-Romero, Susana | |
dc.contributor.author | Amato, Maria Pia | |
dc.contributor.author | Chandraratna, Dhia | |
dc.contributor.author | Clanet, Michel | |
dc.contributor.author | Comi, Giancarlo | |
dc.contributor.author | Fazekas, Franz | |
dc.contributor.author | Hartung, Hans Peter | |
dc.contributor.author | Havrdova, Eva | |
dc.contributor.author | Hemmer, Bernhard | |
dc.contributor.author | Kappos, Ludwig | |
dc.contributor.author | Liblau, Roland | |
dc.contributor.author | Lubetzki, Catherine | |
dc.contributor.author | Marcus, Elena | |
dc.contributor.author | Miller, David H. | |
dc.contributor.author | Olsson, Tomas | |
dc.contributor.author | Pilling, Steve | |
dc.contributor.author | Selmaj, Krysztof | |
dc.contributor.author | Sorensen, Per Soelberg | |
dc.contributor.author | Sormani, Maria Pia | |
dc.contributor.author | Thalheim, Christoph | |
dc.contributor.author | Wiendl, Heinz | |
dc.contributor.author | Zipp, Frauke | |
dc.date.accessioned | 2021-03-04T18:56:02Z | |
dc.date.available | 2021-03-04T18:56:02Z | |
dc.date.issued | 2018 | |
dc.identifier.citation | Montalban X., Gold R., Thompson A. J. , Otero-Romero S., Amato M. P. , Chandraratna D., Clanet M., Comi G., Derfuss T., Fazekas F., et al., "ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis", MULTIPLE SCLEROSIS JOURNAL, cilt.24, ss.96-120, 2018 | |
dc.identifier.issn | 1352-4585 | |
dc.identifier.other | av_8d4d146f-f970-4f0b-8414-a49cfeb7acad | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/95519 | |
dc.identifier.uri | https://doi.org/10.1177/1352458517751049 | |
dc.description.abstract | Background: Multiple sclerosis (MS) is a complex disease with new drugs becoming available in the past years. There is a need for a reference tool compiling current data to aid professionals in treatment decisions. | |
dc.language.iso | eng | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | KLİNİK NEUROLOJİ | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | NEUROSCIENCES | |
dc.subject | Sinirbilim ve Davranış | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Nöroloji | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Temel Bilimler | |
dc.title | ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis | |
dc.type | Makale | |
dc.relation.journal | MULTIPLE SCLEROSIS JOURNAL | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 24 | |
dc.identifier.issue | 2 | |
dc.identifier.startpage | 96 | |
dc.identifier.endpage | 120 | |
dc.contributor.firstauthorID | 251527 | |